Company: CRNX
Filing Date: 2025-06-30
Form Type: 8-K
Source: 0000950170-25-091613
Chunk: 2

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-06-30
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                  
         99.1      Press Release dated June 30, 2025.                                           
 ────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

                                         Crinetics Pharmaceuticals, Inc.        
  Date:      June 30, 2025      By:      /s/ R. Scott Struthers, Ph. D.         
                                         R. Scott Struthers, Ph. D.